GSE69063

Gene expression patterns in blood during human anaphylaxis, trauma, and sepsis

Whole-study status Exploratory only

Dataset can inform exploration but is not strong enough for primary analysis.

Whole-study downloads — these do not apply your sample requirements.

Selected cohort requirements

Samples meeting selected requirements: 0 cases / 0 controls

View matching samples

120 case / 33 control samples elsewhere in the study have incomplete or conflicting evidence; they are not included above

Patient pairs verified in indexed sample metadata: 0

A case/control comparison meeting these requirements is not confirmed.

Counts describe samples, not independent patients. Pair verification uses explicit subject identifiers in indexed sample metadata. Zero verified pairs does not establish that the study is unpaired; reported matched-normal design alone is insufficient.

Summary

Gene expression was profiled in peripheral blood samples collected from patients during anaphylaxis, trauma, or sepsis, and from healthy controls. Patients were recruited from three Australian emergency departments (ED) between March 2011 and June 2013. Samples were collected at ED arrival (T0), 1 hour later (T1), and 3 hours post arrival (T2).

Overall design

The study design consisted of four disease phenotypes (anaphylaxis, sepsis, trauma, healthy controls) and up to 3 time points. Healthy controls were matched to patients within each study.

Source Evidence

4 sources
Source Contribution Status
GEO

Original dataset metadata, sample metadata, source links, and GEO data availability flags.

Sample records
153 GSM samples
Primary source
recount3

Planned trusted source for processed count availability.

No match found
Expression Atlas

Planned source for curated expression experiment links.

No match found
PubMed

Primary GEO citations and related PubMed articles that mention this dataset.

9 linked publications 9 DOIs

Primary publication

  1. Small nucleolar RNA networks are up-regulated during human anaphylaxis. Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology, 2021

Related publications

  1. Genes involved in platelet aggregation and activation are downregulated during acute anaphylaxis in humans. Clinical & translational immunology, 2022
  2. Identification of key genes and development of an identifying machine learning model for sepsis. Inflammation research : official journal of the European Histamine Research Society ... [et al.], 2025
  3. Identification of qualitative characteristics of immunosuppression in sepsis based on immune-related genes and immune infiltration features. Heliyon, 2024
  4. Identification of an Immune-Related Gene Diagnostic Model and Potential Drugs in Sepsis Using Bioinformatics and Pharmacogenomics Approaches. Infection and drug resistance, 2023
  5. Comprehensive integration of diagnostic biomarker analysis and immune cell infiltration features in sepsis via machine learning and bioinformatics techniques. Frontiers in immunology, 2025
  6. Identification of the biological processes, immune cell landscape, and hub genes shared by acute anaphylaxis and ST-segment elevation myocardial infarction. Frontiers in pharmacology, 2023
  7. Identification of Key Genes and Potential Therapeutic Targets in Sepsis-Associated Acute Kidney Injury Using Transformer and Machine Learning Approaches. Bioengineering (Basel, Switzerland), 2025
  8. Elevated FTO alleviates sepsis‑induced acute kidney injury by regulating macrophage inflammatory phenotypes. International journal of molecular medicine, 2026
Available

Metadata Quality Components

Analysis Readiness

Ready after review
97% DE readiness

Contrast completeness

25/25 pts

Both case and control groups are present in the proposed grouping.

Minimum group size

20/20 pts

Each contrast group has at least 2 samples.

Processed data availability

20/20 pts

Processed data is marked available in the GEO index.

Sample decision clarity

15/15 pts

All samples are assigned to a case or control group.

Blocking warnings

7/10 pts

Warnings are present, but none are critical blockers.

Metadata normalization

10/10 pts

Metadata quality is high enough to support downstream handoff.

Blockers

No readiness blockers detected.

Next Steps

  • Verify the proposed sample assignments and case-versus-control comparison against the GEO metadata before using them in DESeq2 or another differential-expression tool.
  • Confirm processed count files and sample identifiers match the exported metadata.

Analysis Preparation Checklist

5/6 ready

Group labels reviewed

Needs review

Siftome proposed case and control labels, but no reviewer confirmation is stored yet.

Open the sample grouping CSV and confirm group labels before analysis.

Minimum sample count met

Ready

Both groups meet the minimum of 2 samples.

Confirm whether the cohort is large enough for the intended statistical analysis.

Processed counts available

Ready

Processed data availability is marked true in the GEO index.

Verify that downloaded processed files contain usable count or expression identifiers.

Ambiguous samples handled

Ready

No review-needed or unassigned samples are present in the proposed grouping.

Review the grouping table for biologically meaningful differences that the automated checks may not detect.

Exclusion decisions recorded

Ready

No hard-excluded samples were detected by the current rules.

Record any manual exclusions in the downstream analysis notes.

Source traceability preserved

Ready

The dataset and sample accessions can be traced back to GEO.

Keep GEO accessions with exported metadata.

Bioinformatician Review

Bioinformatician review required

Ask a bioinformatician to review grouping, count availability, exclusions, and design before DE.

Assay context may require expert handling before DESeq2-style analysis.

Why This Is Ranked Here

Tumor vs normal
Exploratory only Dataset can inform exploration but is not strong enough for primary analysis.

Applied Review Decisions

No active review decisions affect this ranking.

Derived Classifications

  • Assay differs from search intent Microarray Search intent expects bulk RNA-seq. Assay came from Normalization rules.
  • Disease context Sepsis Disease context came from Normalization rules.
  • Likely case group Anaphylaxis 120 samples
  • Likely control group Healthy control 33 samples

Intent Interpretation

  • Downgrade or exclusion reason Downgraded for tissue search because it is a biofluid cohort. Derived from current-intent ranking reasons.

Ranking Facts

Supporting evidence

  • Comparison: Patient biofluid vs healthy control. Specimen: Biofluid. Comparison suitability: 20%.
  • Interpreted disease metadata: Sepsis.
  • Processed data is available for downstream review.
  • External evidence: PubMed links 9 publications; 9 DOIs available: PMID 34228845, PMID 36583159, PMID 37469874, PMID 37662976, PMID 38628767.
  • Publication context: Small nucleolar RNA networks are up-regulated during human anaphylaxis.. Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology, 2021. PMID 34228845. DOI 10.1111/cea.13982.
  • Publication context: Genes involved in platelet aggregation and activation are downregulated during acute anaphylaxis in humans.. Clinical & translational immunology, 2022. PMID 36583159. DOI 10.1002/cti2.1435.
  • Publication context: Identification of the biological processes, immune cell landscape, and hub genes shared by acute anaphylaxis and ST-segment elevation myocardial infarction.. Frontiers in pharmacology, 2023. PMID 37469874. DOI 10.3389/fphar.2023.1211332.
  • Publication context: 6 additional linked PubMed publications are available.

Cautions

  • Downgraded for tissue search because it is a biofluid cohort.
  • Downgraded assay: microarray cohorts are separated from the RNA-seq intent.
  • Blood, plasma, or serum cohort downgraded because this ranking targets tissue tumor-vs-normal comparisons.
  • Overall score capped because comparison suitability is weak for the selected search intent.
  • Comparison suitability score is below the Phase 1 recommended threshold.

Dataset Warnings

Normalized Fields

477 fields

Sample Group Preview

showing 83 of 153 preview rows
Show Hide
Study totals: Case 120 | Control 33 | Unassigned 0 | Excluded 0 | Ambiguous 0 showing 83 of 153 preview rows
Group Role Accession Title Source / characteristics Reason
Anaphylaxis Case GSM1691688 Peripheral blood sample from anaphylaxis patient 249 at Time T0 Peripheral blood sample from anaphylaxis patient 249 at Time T0 Tissue: Peripheral blood; Study: Anaphylaxis study; Disease status: Anaphylaxis; Severity: Moderate; Time point: T0 Explicit characteristic comparison arm detected.
Anaphylaxis Case GSM1691689 Peripheral blood sample from anaphylaxis patient 249 at Time T1 Peripheral blood sample from anaphylaxis patient 249 at Time T1 Tissue: Peripheral blood; Study: Anaphylaxis study; Disease status: Anaphylaxis; Severity: Moderate; Time point: T1 Explicit characteristic comparison arm detected.
Anaphylaxis Case GSM1691690 Peripheral blood sample from anaphylaxis patient 310 at Time T1 Peripheral blood sample from anaphylaxis patient 310 at Time T1 Tissue: Peripheral blood; Study: Anaphylaxis study; Disease status: Anaphylaxis; Severity: Severe; Time point: T1 Explicit characteristic comparison arm detected.
Anaphylaxis Case GSM1691691 Peripheral blood sample from anaphylaxis patient 313 at Time T0 Peripheral blood sample from anaphylaxis patient 313 at Time T0 Tissue: Peripheral blood; Study: Anaphylaxis study; Disease status: Anaphylaxis; Severity: Moderate; Time point: T0 Explicit characteristic comparison arm detected.
Anaphylaxis Case GSM1691692 Peripheral blood sample from anaphylaxis patient 313 at Time T1 Peripheral blood sample from anaphylaxis patient 313 at Time T1 Tissue: Peripheral blood; Study: Anaphylaxis study; Disease status: Anaphylaxis; Severity: Moderate; Time point: T1 Explicit characteristic comparison arm detected.
Anaphylaxis Case GSM1691693 Peripheral blood sample from anaphylaxis patient 318 at Time T0 Peripheral blood sample from anaphylaxis patient 318 at Time T0 Tissue: Peripheral blood; Study: Anaphylaxis study; Disease status: Anaphylaxis; Severity: Severe; Time point: T0 Explicit characteristic comparison arm detected.
Anaphylaxis Case GSM1691694 Peripheral blood sample from anaphylaxis patient 318 at Time T1 Peripheral blood sample from anaphylaxis patient 318 at Time T1 Tissue: Peripheral blood; Study: Anaphylaxis study; Disease status: Anaphylaxis; Severity: Severe; Time point: T1 Explicit characteristic comparison arm detected.
Anaphylaxis Case GSM1691695 Peripheral blood sample from anaphylaxis patient 459 at Time T0 Peripheral blood sample from anaphylaxis patient 459 at Time T0 Tissue: Peripheral blood; Study: Anaphylaxis study; Disease status: Anaphylaxis; Severity: Moderate; Time point: T0 Explicit characteristic comparison arm detected.
Anaphylaxis Case GSM1691696 Peripheral blood sample from anaphylaxis patient 459 at Time T1 Peripheral blood sample from anaphylaxis patient 459 at Time T1 Tissue: Peripheral blood; Study: Anaphylaxis study; Disease status: Anaphylaxis; Severity: Moderate; Time point: T1 Explicit characteristic comparison arm detected.
Anaphylaxis Case GSM1691697 Peripheral blood sample from anaphylaxis patient 568 at Time T0 Peripheral blood sample from anaphylaxis patient 568 at Time T0 Tissue: Peripheral blood; Study: Anaphylaxis study; Disease status: Anaphylaxis; Severity: Severe; Time point: T0 Explicit characteristic comparison arm detected.
Anaphylaxis Case GSM1691698 Peripheral blood sample from anaphylaxis patient 568 at Time T1 Peripheral blood sample from anaphylaxis patient 568 at Time T1 Tissue: Peripheral blood; Study: Anaphylaxis study; Disease status: Anaphylaxis; Severity: Severe; Time point: T1 Explicit characteristic comparison arm detected.
Anaphylaxis Case GSM1691699 Peripheral blood sample from anaphylaxis patient 576 at Time T0 Peripheral blood sample from anaphylaxis patient 576 at Time T0 Tissue: Peripheral blood; Study: Anaphylaxis study; Disease status: Anaphylaxis; Severity: Severe; Time point: T0 Explicit characteristic comparison arm detected.
Anaphylaxis Case GSM1691700 Peripheral blood sample from anaphylaxis patient 576 at Time T1 Peripheral blood sample from anaphylaxis patient 576 at Time T1 Tissue: Peripheral blood; Study: Anaphylaxis study; Disease status: Anaphylaxis; Severity: Severe; Time point: T1 Explicit characteristic comparison arm detected.
Anaphylaxis Case GSM1691701 Peripheral blood sample from anaphylaxis patient 583 at Time T0 Peripheral blood sample from anaphylaxis patient 583 at Time T0 Tissue: Peripheral blood; Study: Anaphylaxis study; Disease status: Anaphylaxis; Severity: Severe; Time point: T0 Explicit characteristic comparison arm detected.
Anaphylaxis Case GSM1691702 Peripheral blood sample from anaphylaxis patient 633 at Time T0 Peripheral blood sample from anaphylaxis patient 633 at Time T0 Tissue: Peripheral blood; Study: Anaphylaxis study; Disease status: Anaphylaxis; Severity: Severe; Time point: T0 Explicit characteristic comparison arm detected.
Anaphylaxis Case GSM1691703 Peripheral blood sample from anaphylaxis patient 633 at Time T1 Peripheral blood sample from anaphylaxis patient 633 at Time T1 Tissue: Peripheral blood; Study: Anaphylaxis study; Disease status: Anaphylaxis; Severity: Severe; Time point: T1 Explicit characteristic comparison arm detected.
Anaphylaxis Case GSM1691704 Peripheral blood sample from anaphylaxis patient 653 at Time T0 Peripheral blood sample from anaphylaxis patient 653 at Time T0 Tissue: Peripheral blood; Study: Anaphylaxis study; Disease status: Anaphylaxis; Severity: Moderate; Time point: T0 Explicit characteristic comparison arm detected.
Anaphylaxis Case GSM1691705 Peripheral blood sample from anaphylaxis patient 653 at Time T1 Peripheral blood sample from anaphylaxis patient 653 at Time T1 Tissue: Peripheral blood; Study: Anaphylaxis study; Disease status: Anaphylaxis; Severity: Moderate; Time point: T1 Explicit characteristic comparison arm detected.
Anaphylaxis Case GSM1691706 Peripheral blood sample from anaphylaxis patient 719 at Time T0 Peripheral blood sample from anaphylaxis patient 719 at Time T0 Tissue: Peripheral blood; Study: Anaphylaxis study; Disease status: Anaphylaxis; Severity: Moderate; Time point: T0 Explicit characteristic comparison arm detected.
Anaphylaxis Case GSM1691707 Peripheral blood sample from anaphylaxis patient 719 at Time T1 Peripheral blood sample from anaphylaxis patient 719 at Time T1 Tissue: Peripheral blood; Study: Anaphylaxis study; Disease status: Anaphylaxis; Severity: Moderate; Time point: T1 Explicit characteristic comparison arm detected.
Anaphylaxis Case GSM1691708 Peripheral blood sample from anaphylaxis patient 732 at Time T1 Peripheral blood sample from anaphylaxis patient 732 at Time T1 Tissue: Peripheral blood; Study: Anaphylaxis study; Disease status: Anaphylaxis; Severity: Severe; Time point: T1 Explicit characteristic comparison arm detected.
Anaphylaxis Case GSM1691709 Peripheral blood sample from anaphylaxis patient 802 at Time T0 Peripheral blood sample from anaphylaxis patient 802 at Time T0 Tissue: Peripheral blood; Study: Anaphylaxis study; Disease status: Anaphylaxis; Severity: Severe; Time point: T0 Explicit characteristic comparison arm detected.
Anaphylaxis Case GSM1691710 Peripheral blood sample from anaphylaxis patient 802 at Time T1 Peripheral blood sample from anaphylaxis patient 802 at Time T1 Tissue: Peripheral blood; Study: Anaphylaxis study; Disease status: Anaphylaxis; Severity: Severe; Time point: T1 Explicit characteristic comparison arm detected.
Anaphylaxis Case GSM1691711 Peripheral blood sample from anaphylaxis patient 819 at Time T0 Peripheral blood sample from anaphylaxis patient 819 at Time T0 Tissue: Peripheral blood; Study: Anaphylaxis study; Disease status: Anaphylaxis; Severity: Moderate; Time point: T0 Explicit characteristic comparison arm detected.
Anaphylaxis Case GSM1691712 Peripheral blood sample from anaphylaxis patient 819 at Time T1 Peripheral blood sample from anaphylaxis patient 819 at Time T1 Tissue: Peripheral blood; Study: Anaphylaxis study; Disease status: Anaphylaxis; Severity: Moderate; Time point: T1 Explicit characteristic comparison arm detected.
Anaphylaxis Case GSM1691713 Peripheral blood sample from anaphylaxis patient 828 at Time T0 Peripheral blood sample from anaphylaxis patient 828 at Time T0 Tissue: Peripheral blood; Study: Anaphylaxis study; Disease status: Anaphylaxis; Severity: Moderate; Time point: T0 Explicit characteristic comparison arm detected.
Anaphylaxis Case GSM1691714 Peripheral blood sample from anaphylaxis patient 828 at Time T1 Peripheral blood sample from anaphylaxis patient 828 at Time T1 Tissue: Peripheral blood; Study: Anaphylaxis study; Disease status: Anaphylaxis; Severity: Moderate; Time point: T1 Explicit characteristic comparison arm detected.
Anaphylaxis Case GSM1691715 Peripheral blood sample from anaphylaxis patient 830 at Time T0 Peripheral blood sample from anaphylaxis patient 830 at Time T0 Tissue: Peripheral blood; Study: Anaphylaxis study; Disease status: Anaphylaxis; Severity: Severe; Time point: T0 Explicit characteristic comparison arm detected.
Anaphylaxis Case GSM1691716 Peripheral blood sample from anaphylaxis patient 830 at Time T1 Peripheral blood sample from anaphylaxis patient 830 at Time T1 Tissue: Peripheral blood; Study: Anaphylaxis study; Disease status: Anaphylaxis; Severity: Severe; Time point: T1 Explicit characteristic comparison arm detected.
Anaphylaxis Case GSM1691717 Peripheral blood sample from anaphylaxis patient 831 at Time T0 Peripheral blood sample from anaphylaxis patient 831 at Time T0 Tissue: Peripheral blood; Study: Anaphylaxis study; Disease status: Anaphylaxis; Severity: Severe; Time point: T0 Explicit characteristic comparison arm detected.
Anaphylaxis Case GSM1691718 Peripheral blood sample from anaphylaxis patient 831 at Time T1 Peripheral blood sample from anaphylaxis patient 831 at Time T1 Tissue: Peripheral blood; Study: Anaphylaxis study; Disease status: Anaphylaxis; Severity: Severe; Time point: T1 Explicit characteristic comparison arm detected.
Anaphylaxis Case GSM1691719 Peripheral blood sample from anaphylaxis patient 833 at Time T0 Peripheral blood sample from anaphylaxis patient 833 at Time T0 Tissue: Peripheral blood; Study: Anaphylaxis study; Disease status: Anaphylaxis; Severity: Moderate; Time point: T0 Explicit characteristic comparison arm detected.
Anaphylaxis Case GSM1691720 Peripheral blood sample from anaphylaxis patient 833 at Time T1 Peripheral blood sample from anaphylaxis patient 833 at Time T1 Tissue: Peripheral blood; Study: Anaphylaxis study; Disease status: Anaphylaxis; Severity: Moderate; Time point: T1 Explicit characteristic comparison arm detected.
Sepsis or systemic inflammatory response Case GSM1691731 Peripheral blood sample from sepsis patient A at Time T0 Peripheral blood sample from sepsis patient A at Time T0 Tissue: Peripheral blood; Study: Sepsis study; Disease status: Sepsis; Severity: Severe; Time point: T0 Explicit sample label case marker detected.
Sepsis or systemic inflammatory response Case GSM1691732 Peripheral blood sample from sepsis patient A at Time T1 Peripheral blood sample from sepsis patient A at Time T1 Tissue: Peripheral blood; Study: Sepsis study; Disease status: Sepsis; Severity: Severe; Time point: T1 Explicit sample label case marker detected.
Sepsis or systemic inflammatory response Case GSM1691733 Peripheral blood sample from sepsis patient A at Time T2 Peripheral blood sample from sepsis patient A at Time T2 Tissue: Peripheral blood; Study: Sepsis study; Disease status: Sepsis; Severity: Severe; Time point: T2 Explicit sample label case marker detected.
Sepsis or systemic inflammatory response Case GSM1691734 Peripheral blood sample from sepsis patient B at Time T1 Peripheral blood sample from sepsis patient B at Time T1 Tissue: Peripheral blood; Study: Sepsis study; Disease status: Sepsis; Severity: Severe; Time point: T1 Explicit sample label case marker detected.
Sepsis or systemic inflammatory response Case GSM1691735 Peripheral blood sample from sepsis patient B at Time T2 Peripheral blood sample from sepsis patient B at Time T2 Tissue: Peripheral blood; Study: Sepsis study; Disease status: Sepsis; Severity: Severe; Time point: T2 Explicit sample label case marker detected.
Sepsis or systemic inflammatory response Case GSM1691736 Peripheral blood sample from sepsis patient C at Time T0 Peripheral blood sample from sepsis patient C at Time T0 Tissue: Peripheral blood; Study: Sepsis study; Disease status: Sepsis; Severity: Severe; Time point: T0 Explicit sample label case marker detected.
Sepsis or systemic inflammatory response Case GSM1691737 Peripheral blood sample from sepsis patient C at Time T1 Peripheral blood sample from sepsis patient C at Time T1 Tissue: Peripheral blood; Study: Sepsis study; Disease status: Sepsis; Severity: Severe; Time point: T1 Explicit sample label case marker detected.
Sepsis or systemic inflammatory response Case GSM1691738 Peripheral blood sample from sepsis patient C at Time T2 Peripheral blood sample from sepsis patient C at Time T2 Tissue: Peripheral blood; Study: Sepsis study; Disease status: Sepsis; Severity: Severe; Time point: T2 Explicit sample label case marker detected.
Sepsis or systemic inflammatory response Case GSM1691750 Peripheral blood sample from sepsis patient D at Time T0 Peripheral blood sample from sepsis patient D at Time T0 Tissue: Peripheral blood; Study: Sepsis study; Disease status: Sepsis; Severity: Severe; Time point: T0 Explicit sample label case marker detected.
Sepsis or systemic inflammatory response Case GSM1691751 Peripheral blood sample from sepsis patient D at Time T1 Peripheral blood sample from sepsis patient D at Time T1 Tissue: Peripheral blood; Study: Sepsis study; Disease status: Sepsis; Severity: Severe; Time point: T1 Explicit sample label case marker detected.
Sepsis or systemic inflammatory response Case GSM1691752 Peripheral blood sample from sepsis patient D at Time T2 Peripheral blood sample from sepsis patient D at Time T2 Tissue: Peripheral blood; Study: Sepsis study; Disease status: Sepsis; Severity: Severe; Time point: T2 Explicit sample label case marker detected.
Sepsis or systemic inflammatory response Case GSM1691753 Peripheral blood sample from sepsis patient E at Time T0 Peripheral blood sample from sepsis patient E at Time T0 Tissue: Peripheral blood; Study: Sepsis study; Disease status: Sepsis; Severity: Severe; Time point: T0 Explicit sample label case marker detected.
Sepsis or systemic inflammatory response Case GSM1691754 Peripheral blood sample from sepsis patient E at Time T1 Peripheral blood sample from sepsis patient E at Time T1 Tissue: Peripheral blood; Study: Sepsis study; Disease status: Sepsis; Severity: Severe; Time point: T1 Explicit sample label case marker detected.
Sepsis or systemic inflammatory response Case GSM1691755 Peripheral blood sample from sepsis patient F at Time T0 Peripheral blood sample from sepsis patient F at Time T0 Tissue: Peripheral blood; Study: Sepsis study; Disease status: Sepsis; Severity: Severe; Time point: T0 Explicit sample label case marker detected.
Sepsis or systemic inflammatory response Case GSM1691756 Peripheral blood sample from sepsis patient F at Time T1 Peripheral blood sample from sepsis patient F at Time T1 Tissue: Peripheral blood; Study: Sepsis study; Disease status: Sepsis; Severity: Severe; Time point: T1 Explicit sample label case marker detected.
Sepsis or systemic inflammatory response Case GSM1691757 Peripheral blood sample from sepsis patient F at Time T2 Peripheral blood sample from sepsis patient F at Time T2 Tissue: Peripheral blood; Study: Sepsis study; Disease status: Sepsis; Severity: Severe; Time point: T2 Explicit sample label case marker detected.
Sepsis or systemic inflammatory response Case GSM1691758 Peripheral blood sample from sepsis patient G at Time T0 Peripheral blood sample from sepsis patient G at Time T0 Tissue: Peripheral blood; Study: Sepsis study; Disease status: Sepsis; Severity: Severe; Time point: T0 Explicit sample label case marker detected.
70 additional case samples are hidden from this preview.
Healthy control Control GSM1691721 Peripheral blood sample from healthy control 927 Peripheral blood sample from healthy control 927 Tissue: Peripheral blood; Study: Anaphylaxis study; Disease status: Healthy control; Severity: N/A; Time point: N/A Sample-local control marker detected.
Healthy control Control GSM1691722 Peripheral blood sample from healthy control 928 Peripheral blood sample from healthy control 928 Tissue: Peripheral blood; Study: Anaphylaxis study; Disease status: Healthy control; Severity: N/A; Time point: N/A Sample-local control marker detected.
Healthy control Control GSM1691723 Peripheral blood sample from healthy control 938 Peripheral blood sample from healthy control 938 Tissue: Peripheral blood; Study: Anaphylaxis study; Disease status: Healthy control; Severity: N/A; Time point: N/A Sample-local control marker detected.
Healthy control Control GSM1691724 Peripheral blood sample from healthy control 941 Peripheral blood sample from healthy control 941 Tissue: Peripheral blood; Study: Anaphylaxis study; Disease status: Healthy control; Severity: N/A; Time point: N/A Sample-local control marker detected.
Healthy control Control GSM1691725 Peripheral blood sample from healthy control 942 Peripheral blood sample from healthy control 942 Tissue: Peripheral blood; Study: Anaphylaxis study; Disease status: Healthy control; Severity: N/A; Time point: N/A Sample-local control marker detected.
Healthy control Control GSM1691726 Peripheral blood sample from healthy control 943 Peripheral blood sample from healthy control 943 Tissue: Peripheral blood; Study: Anaphylaxis study; Disease status: Healthy control; Severity: N/A; Time point: N/A Sample-local control marker detected.
Healthy control Control GSM1691727 Peripheral blood sample from healthy control 944 Peripheral blood sample from healthy control 944 Tissue: Peripheral blood; Study: Anaphylaxis study; Disease status: Healthy control; Severity: N/A; Time point: N/A Sample-local control marker detected.
Healthy control Control GSM1691728 Peripheral blood sample from healthy control 947 Peripheral blood sample from healthy control 947 Tissue: Peripheral blood; Study: Anaphylaxis study; Disease status: Healthy control; Severity: N/A; Time point: N/A Sample-local control marker detected.
Healthy control Control GSM1691729 Peripheral blood sample from healthy control 967 Peripheral blood sample from healthy control 967 Tissue: Peripheral blood; Study: Anaphylaxis study; Disease status: Healthy control; Severity: N/A; Time point: N/A Sample-local control marker detected.
Healthy control Control GSM1691730 Peripheral blood sample from healthy control 970 Peripheral blood sample from healthy control 970 Tissue: Peripheral blood; Study: Anaphylaxis study; Disease status: Healthy control; Severity: N/A; Time point: N/A Sample-local control marker detected.
Healthy control Control GSM1691739 Peripheral blood sample from healthy control 02 Peripheral blood sample from healthy control 02 Tissue: Peripheral blood; Study: Sepsis study; Disease status: Healthy control; Severity: N/A; Time point: N/A Sample-local control marker detected.
Healthy control Control GSM1691740 Peripheral blood sample from healthy control 03 Peripheral blood sample from healthy control 03 Tissue: Peripheral blood; Study: Sepsis study; Disease status: Healthy control; Severity: N/A; Time point: N/A Sample-local control marker detected.
Healthy control Control GSM1691741 Peripheral blood sample from healthy control 04 Peripheral blood sample from healthy control 04 Tissue: Peripheral blood; Study: Sepsis study; Disease status: Healthy control; Severity: N/A; Time point: N/A Sample-local control marker detected.
Healthy control Control GSM1691742 Peripheral blood sample from healthy control 05 Peripheral blood sample from healthy control 05 Tissue: Peripheral blood; Study: Sepsis study; Disease status: Healthy control; Severity: N/A; Time point: N/A Sample-local control marker detected.
Healthy control Control GSM1691743 Peripheral blood sample from healthy control 06 Peripheral blood sample from healthy control 06 Tissue: Peripheral blood; Study: Sepsis study; Disease status: Healthy control; Severity: N/A; Time point: N/A Sample-local control marker detected.
Healthy control Control GSM1691744 Peripheral blood sample from healthy control 07 Peripheral blood sample from healthy control 07 Tissue: Peripheral blood; Study: Sepsis study; Disease status: Healthy control; Severity: N/A; Time point: N/A Sample-local control marker detected.
Healthy control Control GSM1691745 Peripheral blood sample from healthy control 08 Peripheral blood sample from healthy control 08 Tissue: Peripheral blood; Study: Sepsis study; Disease status: Healthy control; Severity: N/A; Time point: N/A Sample-local control marker detected.
Healthy control Control GSM1691746 Peripheral blood sample from healthy control 09 Peripheral blood sample from healthy control 09 Tissue: Peripheral blood; Study: Sepsis study; Disease status: Healthy control; Severity: N/A; Time point: N/A Sample-local control marker detected.
Healthy control Control GSM1691747 Peripheral blood sample from healthy control 10 Peripheral blood sample from healthy control 10 Tissue: Peripheral blood; Study: Sepsis study; Disease status: Healthy control; Severity: N/A; Time point: N/A Sample-local control marker detected.
Healthy control Control GSM1691748 Peripheral blood sample from healthy control 11 Peripheral blood sample from healthy control 11 Tissue: Peripheral blood; Study: Sepsis study; Disease status: Healthy control; Severity: N/A; Time point: N/A Sample-local control marker detected.
Healthy control Control GSM1691749 Peripheral blood sample from healthy control 12 Peripheral blood sample from healthy control 12 Tissue: Peripheral blood; Study: Sepsis study; Disease status: Healthy control; Severity: N/A; Time point: N/A Sample-local control marker detected.
Healthy control Control GSM1691805 Peripheral blood sample from healthy control C13 Peripheral blood sample from healthy control C at Time T0 Tissue: Peripheral blood; Study: Trauma study; Disease status: Healthy control; Severity: ALIVE; Time point: T0 Sample-local control marker detected.
Healthy control Control GSM1691806 Peripheral blood sample from healthy control C14 Peripheral blood sample from healthy control C at Time T0 Tissue: Peripheral blood; Study: Trauma study; Disease status: Healthy control; Severity: ALIVE; Time point: T0 Sample-local control marker detected.
Healthy control Control GSM1691807 Peripheral blood sample from healthy control C15 Peripheral blood sample from healthy control C at Time T0 Tissue: Peripheral blood; Study: Trauma study; Disease status: Healthy control; Severity: ALIVE; Time point: T0 Sample-local control marker detected.
Healthy control Control GSM1691808 Peripheral blood sample from healthy control C16 Peripheral blood sample from healthy control C at Time T0 Tissue: Peripheral blood; Study: Trauma study; Disease status: Healthy control; Severity: ALIVE; Time point: T0 Sample-local control marker detected.
Healthy control Control GSM1691809 Peripheral blood sample from healthy control C17 Peripheral blood sample from healthy control C at Time T0 Tissue: Peripheral blood; Study: Trauma study; Disease status: Healthy control; Severity: ALIVE; Time point: T0 Sample-local control marker detected.
Healthy control Control GSM1691810 Peripheral blood sample from healthy control C18 Peripheral blood sample from healthy control C at Time T0 Tissue: Peripheral blood; Study: Trauma study; Disease status: Healthy control; Severity: ALIVE; Time point: T0 Sample-local control marker detected.
Healthy control Control GSM1691811 Peripheral blood sample from healthy control C19 Peripheral blood sample from healthy control C at Time T0 Tissue: Peripheral blood; Study: Trauma study; Disease status: Healthy control; Severity: ALIVE; Time point: T0 Sample-local control marker detected.
Healthy control Control GSM1691812 Peripheral blood sample from healthy control C20 Peripheral blood sample from healthy control C at Time T0 Tissue: Peripheral blood; Study: Trauma study; Disease status: Healthy control; Severity: ALIVE; Time point: T0 Sample-local control marker detected.
Healthy control Control GSM1691813 Peripheral blood sample from healthy control C21 Peripheral blood sample from healthy control C at Time T0 Tissue: Peripheral blood; Study: Trauma study; Disease status: Healthy control; Severity: ALIVE; Time point: T0 Sample-local control marker detected.
Healthy control Control GSM1691814 Peripheral blood sample from healthy control C22 Peripheral blood sample from healthy control C at Time T0 Tissue: Peripheral blood; Study: Trauma study; Disease status: Healthy control; Severity: ALIVE; Time point: T0 Sample-local control marker detected.
Healthy control Control GSM1691815 Peripheral blood sample from healthy control C23 Peripheral blood sample from healthy control C at Time T0 Tissue: Peripheral blood; Study: Trauma study; Disease status: Healthy control; Severity: ALIVE; Time point: T0 Sample-local control marker detected.
Healthy control Control GSM1691816 Peripheral blood sample from healthy control C24 Peripheral blood sample from healthy control C at Time T0 Tissue: Peripheral blood; Study: Trauma study; Disease status: Healthy control; Severity: ALIVE; Time point: T0 Sample-local control marker detected.

Use as Discovery Cohort

External Validation Finder

Carry Siftome's disease, organism, specimen, assay, data type, and accession into a validation project. Uncertain fields remain Unknown.